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Integrating addiction treatment into primary care
using mobile health technology: protocol for an
implementation research study
Andrew R Quanbeck1*, David H Gustafson1, Lisa A Marsch2, Fiona McTavish1, Randall T Brown3,
Marie-Louise Mares4, Roberta Johnson1, Joseph E Glass5, Amy K Atwood1 and Helene McDowell1

Abstract
Background: Healthcare reform in the United States is encouraging Federally Qualified Health Centers and other
primary-care practices to integrate treatment for addiction and other behavioral health conditions into their
practices. The potential of mobile health technologies to manage addiction and comorbidities such as HIV in these
settings is substantial but largely untested. This paper describes a protocol to evaluate the implementation of an
E-Health integrated communication technology delivered via mobile phones, called Seva, into primary-care settings.
Seva is an evidence-based system of addiction treatment and recovery support for patients and real-time caseload
monitoring for clinicians.
Methods/Design: Our implementation strategy uses three models of organizational change: the Program Planning
Model to promote acceptance and sustainability, the NIATx quality improvement model to create a welcoming
environment for change, and Rogers’s diffusion of innovations research, which facilitates adaptations of innovations
to maximize their adoption potential. We will implement Seva and conduct an intensive, mixed-methods
assessment at three diverse Federally Qualified Healthcare Centers in the United States. Our non-concurrent
multiple-baseline design includes three periods — pretest (ending in four months of implementation preparation),
active Seva implementation, and maintenance — with implementation staggered at six-month intervals across sites.
The first site will serve as a pilot clinic. We will track the timing of intervention elements and assess study outcomes
within each dimension of the Reach, Effectiveness, Adoption, Implementation, and Maintenance framework,
including effects on clinicians, patients, and practices. Our mixed-methods approach will include quantitative (e.g.,
interrupted time-series analysis of treatment attendance, with clinics as the unit of analysis) and qualitative (e.g., staff
interviews regarding adaptations to implementation protocol) methods, and assessment of implementation costs.
Discussion: If implementation is successful, the field will have a proven technology that helps Federally Qualified
Health Centers and affiliated organizations provide addiction treatment and recovery support, as well as a proven
strategy for implementing the technology. Seva also has the potential to improve core elements of addiction
treatment, such as referral and treatment processes. A mobile technology for addiction treatment and
accompanying implementation model could provide a cost-effective means to improve the lives of patients with
drug and alcohol problems.
Trial registration: ClinicalTrials.gov (NCT01963234).
Keywords: Primary care integration, Systems change, E-Health, RE-AIM framework
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Background
Context

This paper describes the protocol for a study on implementing mobile-health technology in primary care. The
study is funded by the United States’ National Institute
on Drug Abuse as part of a request for proposals aimed
at integrating addiction treatment into primary care. Although numerous smartphone applications exist that
address many health problems, primary care clinicians
do not commonly incorporate mobile technology into
patient care [1]. One reason is that very few smartphone
applications have been proven in rigorous trials of effectiveness. Even if an application does have a reliable
evidence base, it must still demonstrate its value to various stakeholders if it is to be widely used. Patients must
see value in the application or they are likely to stop
using it. Clinicians must find it useful to incorporate it
in day-to-day clinical management. Finally, clinic administrators must find that the application works both
clinically and financially to support its use by patients
and staff.
Our study focuses on Federally Qualified Health Centers (FQHCs) in the United States, community-based
organizations that provide primary care and preventive
health services to patients regardless of their ability to
pay. FQHCs (and U.S. primary-care practices in general)
are increasingly being encouraged by healthcare reform
to integrate treatment for addiction and behavioral
health into their practices. HIV testing and prevention
efforts are particularly important for the health of men
and women who use illicit drugs because they are at
higher risk than the general population for acquiring
HIV [2,3]. But transforming primary care to address addiction and HIV will likely add to the work of clinicians,
many of whom already feel overburdened. Previous attempts to integrate addiction treatment into primary
care have largely relied on labor-intensive solutions (e.g.,
adding more staff or having staff do tasks differently), with
mixed results [4].
Our premise is that mobile health technology holds
great promise for FQHCs to reach this complex patient
population. More than two-thirds of individuals with
substance use disorders (SUDs) have had contact with a
primary-care provider in the previous six months [5], for
reasons that may or may not relate to their SUD [6]. But
primary-care providers frequently do not screen for or
treat SUDs, even though recovery support can be effectively administered in primary care [6,7]. Administering
recovery support requires that clinicians receive support
and training in addiction, which are uncommon partly
because of the traditional separation of addiction treatment from primary care [8-10]. Technology may help
address these problems. People with addictions tend to
view technology favorably [11]. They acknowledge more
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drug use and psychiatric symptoms online than in faceto-face interviews [12]. A recent review found positive
outcomes in 29 of 32 randomized trials using personal
computers and cell phones for managing chronic diseases [13]. While some information technologies have
proven efficacious, penetration into practice has been
slow [14]. The potential of mobile health technologies to
manage chronic diseases in FQHCs is substantial, but
remains largely untested.
The mobile-health technology

The integrated system we have developed is an E-Health
integrated communication technology for patients with
addiction called Seva (say’-va; a Sanskrit word for selfless caring). Seva consists of treatment and recovery
support elements. The treatment component is based
on the Therapeutic Education System (TES), a web- and
mobile-based curriculum for addiction treatment with 65
interactive, multimedia, skill-building modules, including
basic cognitive behavioral recovery support skills (e.g.,
refusing drugs, managing thoughts about drug use), life
re-structuring skills (e.g., increasing recreational activities), and skills for preventing HIV, hepatitis, and sexually transmitted infections. Each module ends with a
quiz structured to ensure mastery of key content and
skills. TES uses interactive videos to create experiential
learning environments that help patients learn modeled
behaviors (e.g., progressive muscle relaxation). Randomized trials have found that TES is as efficacious as behavioral therapy delivered by therapists and is superior to
standard substance abuse treatment [15]; that it increases
HIV prevention knowledge and self-reported risk for HIV
[16]; and when it partially replaces clinician-delivered care
in methadone treatment, it also improves opioid abstinence rates [17].
Seva’s recovery support elements are based on A-CHESS,
an evidence-based smartphone program designed to help
people in recovery from drug and alcohol addiction prevent relapse. A-CHESS helps patients meet the challenges
they often face, such as loneliness and isolation, transportation, managing the treatment regimen, and getting informal support. A-CHESS also addresses issues such as
cravings and insufficient coping skills in high-risk situations. A-CHESS is based on research on the principles of
effective continuing care for substance use disorders (long
duration, assertive outreach, monitoring, prompts, action
planning, peer and family support, and case management).
The research team that developed A-CHESS has studied
and designed similar systems that have been effective for
patients suffering from lung cancer, breast cancer, asthma,
and HIV [2,3,18-36]. In a randomized trial of patients
discharged from residential addiction treatment, patients
with A-CHESS had 57% fewer risky drinking days than
patients in the control group [37].
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Although Seva was built from two existing programs,
TES and A-CHESS, the Seva user experiences one seamless system with many links between elements. For example, upon completing a skill-building module, the
patient may be shown a link to a discussion group where
peers are discussing the topic of the module, and provided links to further information on the topic. Similarly,
patients whose responses to check-in items indicate a
potential problem may see a link to skill-building related
to that problem, or be shown personal stories from other
patients who have dealt with the same problem. Patiententered data are also uploaded and presented via a webbased dashboard that FQHC clinicians can use to monitor
the status of their Seva users. The dashboard includes
items that patients self-report using their mobile devices,
such as sleep troubles and relationship problems that may
signal an imminent relapse; whether the patient has
attended recovery meetings or completed other elements
of the treatment plan; and the patient’s relapse risk and
protection factors. The dashboard can be customized for
each clinic to display indicators that clinicians deem important for clinical decision-making.
Study focus: implementation

Because Seva has an established evidence base, this research
focuses mainly on implementation and organizational
impact; some patient-level outcomes are included, but
they will be examined in the aggregate. Our goal is to
implement a system that has already proven effective in
specialty addiction treatment in primary-care settings.
The implementation model we are testing (detailed below)
is distinguished by several characteristics: an effort to actively prepare the environment for implementation; the
use of an organizational coach; the use of rapid-cycle tests;
and an early, specific effort to address sustainability. The
implementation model is rooted in the field of systems
engineering, a multi-disciplinary field that integrates
concepts from psychology, economics, social science, and
statistics. The implementation model reflects the multidisciplinary ethic of systems engineering.
We will study organizational change resulting from
implementing Seva in 3 FQHCs over a three-year period.
We will study elements of our implementation model by
using mixed-methods analysis. Our study seeks answers
to three broad research questions: how can Seva be implemented in primary care settings efficiently and effectively;
to what extent do patients and staff accept and use Seva;
and how does Seva affect clinical care for patients and
staff?

Methods/Design
Implementation model

Our implementation strategy combines three evidencebased organizational change strategies: the Program
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Planning Model (PPM) [38,39], the NIATx quality
improvement model [40,41], and core concepts from
Rogers’s diffusion of innovations research [42]. The
PPM comes from the literature of organizational behavior; NIATx, from systems engineering; and Rogers,
from community-based diffusion. The PPM addresses
interpersonal, organizational and environmental variables
that promote sustainability. By focusing on socio-political
aspects of change in community-based organizations, use
of the PPM has led to greater community acceptance than
seen in comparison groups [38,39]. The NIATx model,
an extensively evaluated and widely adopted organizational change model in addiction treatment, provides
an evidence-based approach to implementation by optimizing processes that create a welcoming environment
for change [40,41]. Rogers’s diffusion of innovations research identified characteristics of innovations associated with successful implementation and sustainability
[42]. Rogers’s research complements the NIATx model
by emphasizing ways to adapt an innovation for a specific setting, thus maximizing its adoption potential.
Combined, these strategies make up the implementation
model shown in Figure 1.
The model has 4 phases: i) ‘Initiate’ involves bringing
together and training key people at each site; ii) ‘Prepare’
ensures that the FQHC environment is welcoming to
Seva, the implementation plan adapts to the unique
characteristics of the FQHC, and the technology is developed to maximize its chance of success; iii) ‘Improve’
involves conducting a series of rapid-cycle tests of ideas
that emerge from earlier phases; and iv) ‘Implement’ involves using, monitoring and sustaining the technology.
Organizational coaching will play a key role in helping
clinics implement Seva successfully. We recently completed a randomized trial in 201 addiction treatment
agencies in which coaching proved to be the most costeffective approach to quality improvement among several strategies tested [43]. An implementation coach will
work with each FQHC to advise, encourage and monitor
progress.
Settings for implementation

We worked with the National Association of Community
Health Centers to identify a set of FQHCs with established
electronic health records. We focused on FQHCs with
electronic health records because healthcare reform has
been pushing FQHCs in this direction, and we believe it
will be important to understand how Seva relates to existing clinic technology. From the pool of FQHCs that met
these criteria, we selected an FQHC affiliated with the
University of Wisconsin as our first implementation site;
as a second site, a relatively small, rural, freestanding
FQHC with integrated behavioral health services (including addiction treatment); and as a third site, an urban
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Figure 1 Implementation model.

FQHC that serves a largely minority population. In selecting sites, we strove to maximize diversity in both patient
populations and organizational structures to better understand how environment affects implementation. We included only three FQHCs in order to conduct an
intensive, mixed-methods assessment at each clinic, which
we believe will be more informative for the ultimate purpose of dissemination than randomizing a larger sample of
organizations and studying implementation at a surface
level.

Activity

Month

3

6

9

Timeline

Data will be collected from each FQHC for 48 months
using a combination of data sources, including electronic
health records, staff surveys/interviews, and patient surveys/interviews. We are collecting staff survey data every 6
months for 36 months, patient survey data every 6 months
for 18 months, and aggregated EHR data for 48 months to
cover the full time frame from the beginning of the pretest
period at FQHC 1 to the end of the posttest period at
the FQHC 3. Figure 2 shows more information about
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Integrate technology
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Prepare implementation
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Figure 2 Project timeline.
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the project timeline. Retrospective data collection will take
place during the pretest period, using aggregated patient
data from clinics’ electronic health records. During the
pretest period, sites will also seek to identify potential patient candidates for recruitment. Full-scale implementation occurs during the subsequent 12 months, during
which the sites receive coaching and actively recruit patients to use Seva. The sites will continue to be monitored
during a post-test/sustainability period. During this period,
sites may continue recruiting patients to use Seva, but
without grant funding for phone/internet support or
organizational coaching.
Coaching for organizational change

The organizational coach for the first (pilot) site will be
a member of the research team with extensive experience in organizational coaching. The next two sites will
be coached by a physician from the pilot site, who will
share firsthand experience in implementing Seva with
subsequent clinics. Each site will have a designated
‘change leader’, a clinical leader at the site who is the
point of contact with the coach and will coordinate implementation activities at the clinic; a ‘site coordinator’,
a clinic employee who will enroll patients in the study
and manage the day-to-day operation of Seva; and a
‘change team’, a group of four to eight clinical and/or
administrative staff members who will help identify and
make the organizational changes necessary to implement
Seva. The coach will make an initial site visit during the
four-month period of active implementation preparation
to create a welcoming environment for Seva. During this
visit, the coach will conduct a walk-through [44] with
change team members (an exercise in which employees
experience the clinic as patients do, to reveal issues that
need to be addressed); a work flow assessment using
flow charting; and a technical assessment of data to be
gathered and procedures needed to conduct the study.
During this preparation period, the coach will also work
with the change leader to ensure that pre-test data are
collected; reviews of Seva are completed by clinical
teams and their concerns addressed; and barriers to implementation rectified. After the initial site visit, for the
remainder of the implementation preparation period and
for the 12-month intervention period, the coach will have
monthly telephone conferences with clinic staff and email
correspondence as necessary to monitor implementation
progress and offer advice and feedback to the staff. The
coach and change leader will also work together to reduce
organizational barriers to implementation.
Study design

Our study uses a non-concurrent multiple-baseline design
in which the start of the intervention period is staggered
at the three sites by six months. The multiple-baseline
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design provides the intervention to all participants, but
isolates the independent variable by introducing the intervention at specified points. Using the clinic as the unit of
analysis, this single-subject approach will closely track the
timing of intervention elements and repeatedly measure
outcomes at the organizational level, including aggregated
effects on clinicians, patients and practices. After pilot
testing Seva at the first FQHC and improving Seva and
the overall implementation strategy, we will introduce
Seva at the second FQHC and then, six months later, at
the third FQHC. Each FQHC acts as its own pretest control. During the 48-month data collection period, core
organizational indicators will be measured via a staff survey (administered every 6 months) and the clinics’ electronic health records (aggregated across patients). While
the non-concurrent multiple-baseline design may not provide as strong a basis for causal inference as a large RCT,
we believe it is the appropriate design for evaluating the
organizational impact of a system that has already been
shown effective in RCTs of patients [45]. We will also collect a set of standard CHESS/TES measures via a patient
survey for comparison to previous studies that tested these
technologies in RCTs, and to conduct exploratory analyses. The patient survey also provides supplemental
clinical information not routinely collected in the clinics
(e.g., addiction severity, quality of life, etc.).
Evaluation framework

Our primary focus is to study how Seva is implemented in
three FQHCs. In the process, we hope to generate insights
on how Seva can be most helpful to organizations, staff
and patients, thereby informing implementation processes
in other FQHCs. Our evaluation includes patient, clinician, and organization-level outcomes. To organize this
multifaceted evaluation, we use the RE-AIM framework
[46]. RE-AIM catalogs the quality, speed and impact of
efforts to translate research into practice by including
measures in five categories: reach, effectiveness, adoption, implementation and maintenance. The measures
we will use are summarized in Table 1, followed by a brief
description of each dimension and selected outcomes.
Reach

In assessing reach, we will determine how many patients
are eligible to use Seva within each clinic, how many are
excluded, how many are invited to participate, and how
many enroll in the study. We will also study how quickly
patients are enrolled after the beginning of the enrollment period. We will assess how representative Seva
enrollees are of the target population (substance using
patients within each clinic) by comparing users to the
target population on key clinical characteristics (e.g.,
treatment attendance, healthcare utilization). Qualitative
assessment will supplement our data collection on reach.
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Table 1 RE-AIM measures
Dimension

Measure

Source

Research
question*

Frequency

Reach

Number of Seva patients (eligible, excluded, enrolled)

Patient survey

2

Pre

Characteristics of participating patients

Effectiveness

2

Pre

2

Continuous

Qualitative assessment- reach

Interview- clinic director

1

Pre

No. patients screened for HIV

EHR

3

Continuous

Healthcare utilization (hospitalizations, ER visits, and
residential addiction treatment)

Patient survey

3

0 m, 6 m, 12 m,
18 m

EHR

3

Continuous

Treatment attendance

Patient survey

3

0 m, 6 m, 12 m,
18 m

EHR

3

Continuous

HIV risk behaviors

Patient survey

3

0 m, 6 m, 12 m,
18 m

Substance use

Seva

3

Weekly

Patient survey

3

0 m, 6 m, 12 m,
18m

Quality of life

Patient survey

3

0 m, 6 m, 12 m,
18 m

Qualitative assessment - effectiveness

Interview - clinic director

1

12 m

Publicly available uniform data
system reports for FQHCs

2

Pre

Staff survey

2

Pre, every 6 m

Adoption (setting) Characteristics of participating clinics vs. general FQHC
population
Readiness for implementation
Adoption (staff)

Patient survey
EHR

Use of Seva by staff (including characteristics)

Adoption (patient) Use of Seva by patients (including characteristics)

Seva log files

2

Continuous

Seva log files

2

Continuous

Staff interviews

1

Pre, every 6 m

Patient interviews

1

12 m

Adoption (staff
and patient)

Qualitative assessment- adoption

Implementation

Stages of Implementation Completion

Staff interviews

1

Pre, every 6 m

Technology acceptance

Staff survey

2

Pre, every 6 m

Adaptations to protocol during intervention period

Staff interviews

1

Pre, every 6 m

Cost of intervention

Staff interviews

1

Pre, every 6 m

Coach logs

1

Continuous

Interview with clinic director, coach

1

12 m

Qualitative assessment - implementation
Maintenance

Sustainability score

Staff survey

1

Pre, every 6 m

Six-month follow-up on all effectiveness measures
(see above) and use of Seva

Seva, Patient survey, EHR

1, 2, 3

Various

Qualitative assessment - maintenance

Interview - clinic director

1, 2

18 m

Source: Re-aim.org; Measuring the Use of the RE-AIM Model Dimension Items Checklist
*(1) How can Seva be implemented in primary care settings efficiently and effectively? (2) To what extent do patients and staff accept and use Seva? (3) How
does Seva affect clinical care for patients and staff?

Our goal is to understand how clinicians perceive or anticipate which patients may benefit most from the system, because — for budget reasons — not all patients
can have Seva, either in this study or in a broader dissemination. (In this study, we can offer Seva to a maximum of 100 patients per clinic.) For example, clinicians
may select patients to enroll who they think will be strong
models for other patients, or patients who have had many
relapses and may benefit from a different treatment

approach. As an implementation-focused study, we strive
not for random selection but instead encourage clinicians
to enroll patients for whom they believe Seva will be most
helpful.
Effectiveness

Our primary effectiveness outcome is substance use.
Other outcomes in the effectiveness domain will help us
understand the impact of Seva on patients’ quality of life,
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HIV risk behaviors, healthcare utilization, and treatment
attendance. We will also examine the extent to which
the system promotes an overall increase in the proportion of substance-use patients screened for HIV. Healthcare utilization data (hospitalization, emergency room
visits, and in-patient psychiatric treatment) will also be
used in the cost analysis described below. Qualitative
assessment of effectiveness will take place through an
interview with the clinic director.
Adoption

In assessing adoption at the clinic level, we will report
how many FQHCs were approached to participate and
how many signed on to implement Seva. We will compare
organizational characteristics of participating FQHCs to
the more than 1,000 FQHCs in the United States, based
on public reports required of these organizations by the
federal government. We will gather qualitative data to assess which aspects of organizational structure affect implementation. To assess adoption at the staff level, clinic site
coordinators will make a list of all staff members who see
potential substance-using patients in primary or behavioral care, and invite these staff to complete surveys six
months prior to the implementation period and every
six months thereafter. The surveys include questions
on job function (i.e., physician, behavioral health staff,
or RN), which will allow us to assess how representative the respondents are of the clinic staff as a whole,
and the Readiness for Implementation Survey [47], an
instrument used to predict the adoption success of information technologies in healthcare. Staff members
and patients will take part in qualitative interviews to
supplement data provided in the surveys to assess
organizational barriers and facilitators related to implementation. We will analyze Seva log files to produce
metrics about patterns of system adoption and use by
patients and staff and assess the characteristics of individuals who use Seva most and least actively.
Implementation

To measure implementation progress, we will adapt our
implementation model into a specific implementation
plan (including timetables) for each clinic. We will employ the Stages of Implementation Completion model
[48] as a guide to assess the degree of implementation.
Each phase of the implementation completion model is
broken down into discrete tasks and events and presented as a checklist. We will assess whether each task/
event was implemented, and the length of time each
one took to implement. Starting at the beginning of the
implementation-planning period (four months prior to
implementation), the checklist will be reviewed and updated every six months by the site coordinator in conjunction with the implementation coach. Adaptations to
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the protocol will be noted. We will also assess implementation costs (see below) and administer the Technology Acceptance Model [49], which helps explain
factors that influence the use of a new technology.
Qualitative assessment of the consistency of the intervention will occur through interviews with the clinic
director and the implementation coach.
Maintenance

To assess maintenance, we will administer the British
National Health Service’s Sustainability Index [50]. The
Sustainability Index assesses factors associated with sustainability potential, such as fit with organizational infrastructure, clinical leadership engagement, and progress
monitoring. The Index also offers guidance, developed
by an international panel of experts, on overcoming weaknesses. Factors measured by the Sustainability Index, along
with those included in the Readiness for Implementation
Survey, will guide us in building a conceptual model of
barriers and facilitators to implementation. Assessing
maintenance at the individual level includes monitoring
of effectiveness measures (including substance use and
quality of life) at the 18-month mark, 6 months after
grant funding for phones and internet access ends. We
will examine data on Seva use at the staff and patient
levels to assess long-term maintenance of Seva. Qualitative interviews with clinic directors will assess the degree of institutionalization of Seva within organizations,
how Seva aligns with clinical business models, and
whether and how Seva was adapted after the active implementation period to promote maintenance.
Analysis

We will use a mixed-method approach, using both
quantitative and qualitative methods, to assess our implementation model. Our analysis follows guidelines for
mixed-methods research promulgated by the NIH Office
of Behavioral and Social Sciences Research [51]. Because
this is a study of the organizational impact of Seva, there
will be no single-patient analyses; all analyses will be
aggregated across patients.
Analysis of quantitative outcomes will proceed on three
fronts:
1. Descriptive statistics will be used to assess relevant
Reach outcomes.
2. Interrupted time series analysis will compare
selected Effectiveness and Maintenance outcomes
within a clinic before and after implementation. We
will assess whether our implementation model
promotes the successful installation and use of Seva
using linear regression models, with each analysis
having two time-series segments representing means
and slopes before and after implementation. A test
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of the regression coefficient for implementation (a
dichotomous variable indicating whether the time
point occurred before or after implementation) will
allow us to examine differences in the mean change
at implementation. Differences in slope from pre- to
post-implementation will be tested using the coefficient
for the implementation x month interaction, where
‘month’ is a continuous variable indicating the
month of measurement. Weighted least squares
analysis will be used to account for potential
differences in the number of patients or staff
reporting outcomes within each clinic across time.
Given the limited degrees of freedom, no covariates
will be included in the models.
3. Drawing from conventional approaches to
single-subject analysis, we will also compare selected
RE-AIM outcomes within and across the clinics
using data visualization [52] to determine whether
the shifts between intervention phases of the study
generated shifts in the level, trend, and variability of
performance [53]. This will allow us to evaluate the
immediacy, consistency and magnitude of the
observed effects [52].
The qualitative analysis is designed to:
1. Understand the environments in which Seva is
implemented, how Seva was tailored to fit each
environment, and the processes used to tailor Seva.
Focus groups and observational and interview data
will help us understand the environment and the
processes used to tailor Seva.
2. Provide insights into the quantitative results. We
will interview key stakeholders following each wave
of surveys. As within- and across-site findings
emerge, we will interview people who can help
inform the findings.
3. Understand the barriers to and facilitators of
implementing and sustaining Seva and how they
relate to outcomes. Key stakeholders will be asked to
reflect on reach, outcomes, adoption at the setting
level, staff participation, implementation, and
long-term effects.
4. Prompt informants to reflect upon how they might
advise a similar FQHC to integrate Seva.
We will collect, transcribe and analyze field notes
and interviews collected during each implementation
phase using AtlasTi. The qualitative analysis will follow
grounded theory to build a conceptual model of Seva’s
implementation. Two researchers will independently analyze interviews that represent different organization-level
stakeholders, and then meet to discuss and reconcile
differences in interpretation. Because Readiness for
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Implementation Survey and Sustainability Index factors
are associated with adoption and sustainability, we will
include these factors as a priori themes, while seeking
new insights generated from the interviews. Researchers
will then code the remaining interviews, comparing
themes to distinguish different types of organizations
and conditions. To assure coding consistency, every fourth
interview will be double-coded. Significant inconsistencies
will be discussed and recoded. Finally, we will categorize
the themes into a working model.
Economic analysis

The sustainability of Seva will depend on both its effects
and its cost. Our cost analysis is conducted from the
adopting FQHC’s perspective and is intended to provide
estimates of the costs to implement and operate Seva
within an FQHC. The cost data collection instrument
follows guidelines for economic evaluation of implementation strategies [54]. It has been adapted from a cost
collection instrument we used in a previous quality improvement study [43]. The cost collection instrument
will track fixed costs of implementation, including system development costs and research costs related to development of the implementation strategy. The analysis
separates these one-time, fixed costs from variable costs
related to executing the implementation strategy, including staff salaries (with fringe benefits) for training patients and attending project meetings. We will also track
operating costs, such as smartphones, monthly data
plans, and IT and clinician time for maintaining and improving Seva. The cost data collection instrument will
be administered in semi-annual interviews with staff
members from the participating clinics and research
team during the intervention period. The coach will also
keep a detailed log of contacts with clinic staff to assess
staff participation during the intervention. We will estimate the cost of implementing Seva by totaling the time
spent by coaches and clinicians during the implementation phase (using coach logs) and then multiplying the
hours by relevant wage rates by job classification. We
will add any non-personnel costs, such as travel to site
visits, the cost of teleconferencing services for follow-up
calls, etc. Any free services will be documented. Costs
incurred by patients are outside the scope of the
evaluation.
Evidence suggests that using Seva in a manner that
promotes integrative care will benefit FQHCs financially.
Research has shown that drug users who receive regular
drug abuse care with regular medical care are less likely
to be hospitalized than those who receive only regular
medical care alone, regular drug abuse care alone, or
neither [55]. For patients with substance-abuse-related
medical conditions, integrated care can lower costs
through reduced hospitalization rates, inpatient days,
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and emergency-room use [56]. We will assess changes in
the healthcare services provided to patients by collecting
healthcare utilization data using a combination of electronic health records and self-report. We will analyze
these outcomes using our multiple baseline design to determine whether the costs of implementation are offset
by benefits in terms of reduced healthcare utilization.
Ethics

The study received approval from the Medical Sciences Institutional Review Board at the University of
Wisconsin–Madison and is registered at ClinicalTrials.
gov (NCT01963234).
Trial status

At time of submission, the research team is entering the
pre-implementation period at the pilot clinic. Implementation of Seva with patients and staff is slated to begin
during March 2014.

Discussion
This research adds to the literature on strategies for integrating addiction treatment into primary care. Our study
represents an advanced use of mobile health technology in
primary care. Seva may function as a clinician-extender
because it can provide much of the education and ongoing
therapeutic support that patients with substance use disorders need, allowing clinicians to focus on providing the
primary care they are trained to deliver. Seva is unique for
giving clinicians a way to regularly monitor their patients’
progress outside the clinic through self-reported substance
use, appointment attendance, and risk/protection factors.
If implementation proves successful, the field will have
a proven strategy for implementing and sustaining an
effective technology to help address addiction treatment
and recovery support in FQHCs.
Limitations

Early experience has uncovered a host of unanswered
questions related to data sharing, security and interoperability that have been difficult to resolve. For instance,
receiving IRB approval for the project was a complex
undertaking. Issues related to data sharing are proving
to be difficult to standardize from one clinic (and one
electronic health record system) to the next. Risk aversion
to data sharing may be a formidable challenge to full-scale
integration of mobile health technology in primary care.
We are currently developing a framework that describes
different arrangements for integrating mobile health data
into electronic health records, personal health records,
mobile devices, and clinical data warehouses.
Our early encounters with FQHCs have revealed
organizational differences that will be difficult to account
for statistically. For instance, one clinic routinely screens
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for addiction using standardized screening instruments,
while another clinic identifies addiction through conversations with patients. Such pre-implementation differences must be accounted for qualitatively to accurately
assess changes in the process of care. If implementation
is successful, Seva may help reduce variation in clinics’
approaches to core elements of addiction treatment (including referral and treatment processes), although it is
evident that different clinics start from very different
places in important respects.
Finally, the patient-level RCTs that form the evidence
base for Seva did not include measures of healthcare
utilization (e.g., ER visits). As we shift towards an
organization-level focus in this study of implementation, we seek to understand whether Seva might help
patients access health resources more predictably and
cost-efficiently. We do not, however, have direct evidence from previous RCTs to support the hypothesis
that Seva will reduce healthcare utilization, and analyses
related to healthcare utilization should be considered
exploratory. Likewise, other outcomes included in our
evaluation (for example, quality of life) were unmeasured in the previous RCTs that evaluated TES and ACHESS. We added these measures after consulting the
RE-AIM model dimension checklist (available at www.
re-aim.hnfe.vt.edu).

Conclusion
Developing an effective technology for the treatment
and continuing care of substance use disorders, and disseminating the technology widely and efficiently, is a
matter of urgency given the profound costs of SUDs. Although evidence shows that treatment for substance use
disorders has wide-ranging benefits, such care — routine
for many other chronic illnesses — is rare in primary
care. A model for implementing a mobile technology to
support the treatment of substance use disorders could
provide a cost-effective means to improve the lives of
patients with drug and alcohol problems. Results of the
research will be published as they become available.
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